MICHELETTO, CLAUDIO
 Distribuzione geografica
Continente #
EU - Europa 1.044
NA - Nord America 1.029
AS - Asia 379
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.458
Nazione #
US - Stati Uniti d'America 1.021
GB - Regno Unito 333
CN - Cina 266
IT - Italia 213
SE - Svezia 99
FR - Francia 86
IE - Irlanda 75
DE - Germania 61
RU - Federazione Russa 61
FI - Finlandia 47
SG - Singapore 43
JP - Giappone 25
PL - Polonia 23
HK - Hong Kong 15
UA - Ucraina 15
BE - Belgio 10
IN - India 7
MY - Malesia 7
CA - Canada 6
AT - Austria 5
CZ - Repubblica Ceca 4
KR - Corea 4
VN - Vietnam 4
CH - Svizzera 3
ES - Italia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BG - Bulgaria 2
MX - Messico 2
NL - Olanda 2
PE - Perù 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
HR - Croazia 1
LK - Sri Lanka 1
RO - Romania 1
Totale 2.458
Città #
Southend 280
Chandler 226
Jacksonville 125
Ashburn 77
Dublin 75
Redmond 69
Ann Arbor 59
Beijing 51
Verona 44
Houston 43
Woodbridge 41
New York 39
Lawrence 32
Princeton 32
Boardman 27
Jinan 25
Singapore 25
Wilmington 25
Sindelfingen 21
Helsinki 20
Milan 20
Tokyo 19
Changsha 18
Rome 18
Shenyang 16
Nanjing 15
Bologna 13
Ningbo 13
Hong Kong 12
Taizhou 12
Seattle 10
Zhengzhou 10
Hebei 9
Tianjin 9
Brussels 8
Falls Church 8
Haikou 8
Lanzhou 8
Kuala Lumpur 7
Taiyuan 7
City of Westminster 6
Dallas 6
Fuzhou 6
Jiaxing 6
Kent 6
Auburn Hills 5
Chicago 5
Hangzhou 5
Lancaster 5
Norwalk 5
Redwood City 5
Toronto 5
Ancona 4
Boydton 4
Brno 4
Delhi 4
Dongguan 4
Los Angeles 4
Lozzo Atestino 4
Munich 4
Naples 4
Palermo 4
Seoul 4
Düsseldorf 3
Guangzhou 3
Menlo Park 3
Nanchang 3
Negrar 3
Riyadh 3
Turin 3
Vienna 3
Abbiategrasso 2
Acquedolci 2
Altopascio 2
Bari 2
Barnet 2
Bonsecours 2
Brescia 2
Chennai 2
Clearwater 2
Cortona 2
Dong Ket 2
Dubai 2
Genoa 2
Ghent 2
Grezzana 2
Hendaye 2
Huskvarna 2
Juarez 2
Lima 2
Lomas de Zamora 2
London 2
Madrid 2
Manchester 2
Mercato San Severino 2
Mesagne 2
Morbegno 2
Oppeano 2
Osaka 2
Poggibonsi 2
Totale 1.767
Nome #
Cost analysis of GER-induced asthma: a controlled study vs. atopic asthma of comparable severity. 244
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management 184
A two-stage logistic Model Based on the Measurament of Pro-Infectious Cytokines in Bronchial Secretions for Assessing Bacterial, Viral and Non-Infectious Origin of COPD Exacerbation - Original Research 99
A MCh test pre-post esophageal acidification in detecting GER-related asthma. 96
Lung metastasis from TTF-1 positive sigmoid adenocarcinoma. pitfalls and management. 90
Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma. 84
Reference urinary LTE4 levels in normal individuals: a pilot study. 82
Effect of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma 81
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 76
PATTERN OF AIRWAY INFLAMMATION AND REMODELLING IN MILD PERSISTENT ATOPIC ASTHMA AND IN MILD PERSISTENT ASTHMA RELATED TO GASTROESOPHAGEAL REFLUX 74
Changes in total IgE plasma concentration measured at the third month during anti-IgE treatment predict future exacerbation rates in difficult-to-treat atopic asthma: a pilot study. 73
Diagnostic management of occult nodal lymphangioleiomyomatosis detected during pelvic cancer staging. Localized finding or systemic disease? 72
Nasal and bronchial tolerability of Rofecoxib in patients with aspirin induced asthma. 70
Assessment of COVID-19 progression on day 5 from symptoms onset 69
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 68
Omalizumab management beyond clinical trials: the added value of a network model 66
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer 66
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 63
PIKO-1, an effective, handy device for the patient's personal PEFR and FEV1 electronic long-term monitoring. 61
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 61
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 59
Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study 59
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 57
Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics 56
Nasal and Bronchial Tolerability of Rofecoxib in Patients with Aspirin induced Asthma 53
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 51
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management 50
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 48
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 46
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response 45
Multidisciplinary management in type 2 inflammatory disease 44
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease 34
Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol 29
Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times 25
Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance 22
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 16
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 14
Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy 12
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments 10
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence 6
Totale 2.515
Categoria #
all - tutte 8.685
article - articoli 8.685
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020147 0 4 1 15 18 16 5 12 3 17 37 19
2020/2021327 82 41 4 34 30 31 19 12 20 19 29 6
2021/2022366 52 113 12 22 8 9 5 22 13 8 25 77
2022/2023628 39 71 56 110 64 120 7 33 73 6 30 19
2023/2024497 27 38 47 47 45 78 26 36 12 28 77 36
2024/2025125 78 47 0 0 0 0 0 0 0 0 0 0
Totale 2.515